BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$80.60 USD
+1.93 (2.45%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $80.59 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Bio-Techne Corp [TECH]
Reports for Purchase
Showing records 81 - 100 ( 188 total )
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Cell Therapy and Bioprocess Adding Momentum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Protein vs. Dx/Genomics or Buy vs. Sell
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Life Science Product Momentum; Raise Rating to OW with $600 Price Target
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department